Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- The Cues in Pharma Communication (2)
April 16, 2001
- NEC Develops Home Health Management System Using Internet
April 9, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF
April 9, 2001
- Medical Device Industry to Prohibit Financial Support for Social Gatherings of Medical Institutions
April 9, 2001
- Bayer's Pharma Sales Reach \102 Billion: Mr Kleedehn
April 9, 2001
- New Compulsory Standards to Be Introduced for Respirators
April 9, 2001
- BUSINESS NEWS IN BRIEF
April 9, 2001
- World News in Brief
April 9, 2001
- Eisai Signs Research Contract with Prof. Yanagisawa of Texas University
April 9, 2001
- Joint GL for Genetic Examinations Drafted by 8 Medical Societies
April 9, 2001
- More than 80% of Firms Demand Permission for Complete Contract Manufacturing: Survey
April 9, 2001
- Need for Public Education about Sleep Disorder Stressed: Professor
April 9, 2001
- Ono Outsources Gene Functional Analysis Project to Hitachi
April 9, 2001
- Accurate Information Needed to Overcome Bad Image of Hypnotics: Fujisawa/Sanofi-Synthelabo Seminar
April 9, 2001
- Zeria Aims at \80 Bil. Sales, Net Profit Ratio of 10% in 2005
April 9, 2001
- Taisho, Arena Tie Up for GPCR Discovery Research
April 9, 2001
- Amended Commercial Law to Accelerate Drug Industry Reorganization:Ihoken
April 9, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
April 9, 2001
- OTC News in Brief
April 9, 2001
- REGULATORY NEWS IN BRIEF -2-
April 9, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…